Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 279

1.

AL amyloidosis with a localized B cell neoplasia.

Stuhlmann-Laeisz C, Schönland SO, Hegenbart U, Oschlies I, Baumgart JV, Krüger S, Röcken C.

Virchows Arch. 2019 Mar;474(3):353-363. doi: 10.1007/s00428-019-02527-7. Epub 2019 Jan 24.

PMID:
30680453
2.

Amyloidomas of the nervous system: a monoclonal B-cell disorder with monotypic amyloid light chain lambda amyloid production.

Laeng RH, Altermatt HJ, Scheithauer BW, Zimmermann DR.

Cancer. 1998 Jan 15;82(2):362-74.

PMID:
9445195
3.

IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.

Gachard N, Parrens M, Soubeyran I, Petit B, Marfak A, Rizzo D, Devesa M, Delage-Corre M, Coste V, Laforêt MP, de Mascarel A, Merlio JP, Bouabdhalla K, Milpied N, Soubeyran P, Schmitt A, Bordessoule D, Cogné M, Feuillard J.

Leukemia. 2013 Jan;27(1):183-9. doi: 10.1038/leu.2012.257. Epub 2012 Sep 4.

PMID:
22944768
4.

Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.

Cao XX, Meng Q, Cai H, He TH, Zhang CL, Su W, Sun J, Li Y, Xu W, Zhou DB, Li J.

Ann Hematol. 2017 Jun;96(6):971-976. doi: 10.1007/s00277-017-2968-z. Epub 2017 Mar 9.

PMID:
28280994
5.

Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies.

Solomon A, Weiss DT, Macy SD, Antonucci RA.

Am J Pathol. 1990 Oct;137(4):855-62.

6.

Clone-specific MYD88 L265P and CXCR4 mutation status can provide clinical utility in suspected Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.

Burnworth B, Wang Z, Singleton TP, Bennington A, Fritschle W, Bennington R, Brodersen LE, Wells DA, Loken MR, Zehentner BK.

Leuk Res. 2016 Dec;51:41-48. doi: 10.1016/j.leukres.2016.10.008. Epub 2016 Oct 18.

PMID:
27890075
7.
8.

Uncommon lymphoplasmacytic lymphoma with IgA paraproteinemia: a challenging clinical diagnosis solved by MYD88 mutation analysis.

Martino G, Marra A, Ascani S, Sportoletti P.

Ann Hematol. 2019 Jun;98(6):1507-1508. doi: 10.1007/s00277-018-3545-9. Epub 2018 Nov 13. No abstract available.

PMID:
30426157
9.

Metachronous/concomitant B-cell neoplasms with discordant light-chain or heavy-chain isotype restrictions: evidence of distinct B-cell neoplasms rather than clonal evolutions.

Wei Q, Sebastian S, Papavassiliou P, Rehder C, Wang E.

Hum Pathol. 2014 Oct;45(10):2063-76. doi: 10.1016/j.humpath.2014.06.021. Epub 2014 Jul 17.

PMID:
25179408
10.

MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.

Hamadeh F, MacNamara SP, Aguilera NS, Swerdlow SH, Cook JR.

Mod Pathol. 2015 Apr;28(4):564-74. doi: 10.1038/modpathol.2014.120. Epub 2014 Sep 12.

11.

Analysis of V(lambda)-J(lambda) expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambdaIII) as a new amyloid-associated germline gene segment.

Perfetti V, Casarini S, Palladini G, Vignarelli MC, Klersy C, Diegoli M, Ascari E, Merlini G.

Blood. 2002 Aug 1;100(3):948-53.

PMID:
12130507
12.

Lack of expression of surface immunoglobulin light chains in B-cell non-Hodgkin lymphomas.

Kaleem Z, Zehnbauer BA, White G, Zutter MM.

Am J Clin Pathol. 2000 Mar;113(3):399-405.

PMID:
10705821
13.

Intravascular large B-cell lymphoma secondary to lymphoplasmacytic lymphoma: a case report and review of literature with clonality analysis.

Tanaka Y, Kobayashi Y, Maeshima AM, Oh SY, Nomoto J, Fukuhara S, Kitahara H, Munakata W, Suzuki T, Maruyama D, Tobinai K.

Int J Clin Exp Pathol. 2015 Mar 1;8(3):3339-43. eCollection 2015. Review.

14.

Detection of immunoglobulin light-chain restriction in cutaneous B-cell lymphomas by ultrasensitive bright-field mRNA in situ hybridization.

Minca EC, Wang H, Wang Z, Lanigan C, Billings SD, Luo Y, Tubbs RR, Ma XJ.

J Cutan Pathol. 2015 Feb;42(2):82-9. doi: 10.1111/cup.12415. Epub 2014 Dec 15.

PMID:
25363373
15.

Branched-chain in situ hybridization for κ and λ light chains: A powerful ancillary technique for determining B-cell clonality in cytology samples.

Arora K, Chebib I, Zukerberg L, Gandhi M, Rivera M, Ting D, Deshpande V.

Cancer Cytopathol. 2016 Mar;124(3):203-12. doi: 10.1002/cncy.21629. Epub 2015 Nov 2.

17.

Gamma heavy chain disease lacks the MYD88 L265p mutation associated with lymphoplasmacytic lymphoma.

Hamadeh F, MacNamara S, Bacon CM, Sohani AR, Swerdlow SH, Cook JR.

Haematologica. 2014 Sep;99(9):e154-5. doi: 10.3324/haematol.2014.108688. Epub 2014 May 23. No abstract available.

18.

Kappa and lambda light chain mRNA in situ hybridization compared to flow cytometry and immunohistochemistry in B cell lymphomas.

Rimsza LM, Day WA, McGinn S, Pedata A, Natkunam Y, Warnke R, Cook JR, Marafioti T, Grogan TM.

Diagn Pathol. 2014 Jul 21;9:144. doi: 10.1186/1746-1596-9-144.

19.

Immunophenotypic analysis of abnormal plasma cell clones in bone marrow of primary systemic light chain amyloidosis patients.

Hu Y, Wang M, Chen Y, Chen X, Fang F, Liu S, Zhang Y, Wu X, Zhu P.

Chin Med J (Engl). 2014;127(15):2765-70.

PMID:
25146610
20.

Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma.

Randen U, Trøen G, Tierens A, Steen C, Warsame A, Beiske K, Tjønnfjord GE, Berentsen S, Delabie J.

Haematologica. 2014 Mar;99(3):497-504. doi: 10.3324/haematol.2013.091702. Epub 2013 Oct 18.

Supplemental Content

Support Center